ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 189 filers reported holding ANI PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,697,000 | -62.3% | 23,285 | -57.5% | 0.04% | -57.7% |
| Q2 2019 | $4,504,000 | +524.7% | 54,792 | +436.1% | 0.10% | +506.2% |
| Q1 2019 | $721,000 | +68.1% | 10,221 | +7.4% | 0.02% | +45.5% |
| Q4 2018 | $429,000 | +18.8% | 9,518 | +47.6% | 0.01% | +37.5% |
| Q3 2018 | $361,000 | -85.9% | 6,450 | -83.1% | 0.01% | -83.7% |
| Q2 2018 | $2,568,000 | -15.2% | 38,233 | -26.5% | 0.05% | -23.4% |
| Q1 2018 | $3,030,000 | -4.7% | 52,036 | +7.7% | 0.06% | -7.2% |
| Q4 2017 | $3,181,000 | +118.0% | 48,328 | +119.8% | 0.07% | +53.3% |
| Q3 2016 | $1,459,000 | -67.3% | 21,986 | -72.5% | 0.04% | -69.4% |
| Q2 2016 | $4,459,000 | +100.5% | 79,889 | +20.9% | 0.15% | +129.7% |
| Q1 2016 | $2,224,000 | -69.0% | 66,079 | -58.5% | 0.06% | -62.1% |
| Q4 2015 | $7,183,000 | – | 159,307 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |